NDRA
Price
$6.60
Change
+$0.03 (+0.46%)
Updated
Jul 25 closing price
Capitalization
4.44M
QTRX
Price
$5.85
Change
+$0.34 (+6.17%)
Updated
Jul 25 closing price
Capitalization
907.82M
15 days until earnings call
Interact to see
Advertisement

NDRA vs QTRX

Header iconNDRA vs QTRX Comparison
Open Charts NDRA vs QTRXBanner chart's image
ENDRA Life Sciences
Price$6.60
Change+$0.03 (+0.46%)
Volume$19.43K
Capitalization4.44M
Quanterix
Price$5.85
Change+$0.34 (+6.17%)
Volume$838.3K
Capitalization907.82M
NDRA vs QTRX Comparison Chart in %
Loading...
NDRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NDRA vs. QTRX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDRA is a Hold and QTRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (NDRA: $6.60 vs. QTRX: $5.85)
Brand notoriety: NDRA and QTRX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NDRA: 1% vs. QTRX: 111%
Market capitalization -- NDRA: $4.44M vs. QTRX: $907.82M
NDRA [@Medical Specialties] is valued at $4.44M. QTRX’s [@Medical Specialties] market capitalization is $907.82M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NDRA’s FA Score shows that 1 FA rating(s) are green whileQTRX’s FA Score has 1 green FA rating(s).

  • NDRA’s FA Score: 1 green, 4 red.
  • QTRX’s FA Score: 1 green, 4 red.
According to our system of comparison, NDRA is a better buy in the long-term than QTRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NDRA’s TA Score shows that 4 TA indicator(s) are bullish while QTRX’s TA Score has 4 bullish TA indicator(s).

  • NDRA’s TA Score: 4 bullish, 5 bearish.
  • QTRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, QTRX is a better buy in the short-term than NDRA.

Price Growth

NDRA (@Medical Specialties) experienced а -7.30% price change this week, while QTRX (@Medical Specialties) price change was +8.94% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

QTRX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QTRX($908M) has a higher market cap than NDRA($4.44M). NDRA YTD gains are higher at: 5.431 vs. QTRX (-44.967). NDRA has higher annual earnings (EBITDA): -12.09M vs. QTRX (-39.79M). QTRX has more cash in the bank: 321M vs. NDRA (3.34M). NDRA has less debt than QTRX: NDRA (434K) vs QTRX (41.5M). QTRX has higher revenues than NDRA: QTRX (121M) vs NDRA (0).
NDRAQTRXNDRA / QTRX
Capitalization4.44M908M0%
EBITDA-12.09M-39.79M30%
Gain YTD5.431-44.967-12%
P/E RatioN/AN/A-
Revenue0121M-
Total Cash3.34M321M1%
Total Debt434K41.5M1%
FUNDAMENTALS RATINGS
NDRA vs QTRX: Fundamental Ratings
NDRA
QTRX
OUTLOOK RATING
1..100
9882
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
3787
P/E GROWTH RATING
1..100
9100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTRX's Valuation (28) in the Pharmaceuticals Major industry is in the same range as NDRA (59) in the Biotechnology industry. This means that QTRX’s stock grew similarly to NDRA’s over the last 12 months.

QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as NDRA (100) in the Biotechnology industry. This means that QTRX’s stock grew similarly to NDRA’s over the last 12 months.

QTRX's SMR Rating (93) in the Pharmaceuticals Major industry is in the same range as NDRA (100) in the Biotechnology industry. This means that QTRX’s stock grew similarly to NDRA’s over the last 12 months.

NDRA's Price Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for QTRX (87) in the Pharmaceuticals Major industry. This means that NDRA’s stock grew somewhat faster than QTRX’s over the last 12 months.

NDRA's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for QTRX (100) in the Pharmaceuticals Major industry. This means that NDRA’s stock grew significantly faster than QTRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NDRAQTRX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NDRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGGSX30.510.32
+1.06%
Baillie Gifford US Equity Growth I
GTSDX8.960.06
+0.67%
Invesco Small Cap Growth C
SCIUX11.690.03
+0.26%
Invesco Income Advantage U.S. Fund R5
TEMTX26.53-0.02
-0.08%
Franklin Mutual Shares C
PDECX17.32-0.08
-0.46%
PGIM Jennison Emerging Markets Eq Opps C

QTRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with ILMN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then ILMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTRX
1D Price
Change %
QTRX100%
+6.17%
ILMN - QTRX
50%
Loosely correlated
+4.48%
TWST - QTRX
49%
Loosely correlated
+2.59%
RVTY - QTRX
47%
Loosely correlated
+1.67%
BLFS - QTRX
45%
Loosely correlated
+1.44%
A - QTRX
44%
Loosely correlated
-0.14%
More